8-144516739-G-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The ENST00000621189.4(RECQL4):​c.-692C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,530,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

RECQL4
ENST00000621189.4 5_prime_UTR_premature_start_codon_gain

Scores

11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: -0.0320

Publications

0 publications found
Variant links:
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]
RECQL4 Gene-Disease associations (from GenCC):
  • Baller-Gerold syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
  • Rothmund-Thomson syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Rothmund-Thomson syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • osteosarcoma
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • rapadilino syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023153663).

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000621189.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RECQL4
NM_004260.4
MANE Select
c.380C>Tp.Pro127Leu
missense
Exon 5 of 21NP_004251.4
RECQL4
NM_001413023.1
c.-692C>T
5_prime_UTR_premature_start_codon_gain
Exon 4 of 19NP_001399952.1
RECQL4
NM_001413041.1
c.-754C>T
5_prime_UTR_premature_start_codon_gain
Exon 4 of 19NP_001399970.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RECQL4
ENST00000621189.4
TSL:1
c.-692C>T
5_prime_UTR_premature_start_codon_gain
Exon 4 of 20ENSP00000483145.1
RECQL4
ENST00000617875.6
TSL:1 MANE Select
c.380C>Tp.Pro127Leu
missense
Exon 5 of 21ENSP00000482313.2
RECQL4
ENST00000621189.4
TSL:1
c.-692C>T
5_prime_UTR
Exon 4 of 20ENSP00000483145.1

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152206
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000568
AC:
10
AN:
176054
AF XY:
0.0000746
show subpopulations
Gnomad AFR exome
AF:
0.000552
Gnomad AMR exome
AF:
0.0000448
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000644
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000131
AC:
18
AN:
1377852
Hom.:
0
Cov.:
35
AF XY:
0.0000133
AC XY:
9
AN XY:
677140
show subpopulations
African (AFR)
AF:
0.000457
AC:
14
AN:
30612
American (AMR)
AF:
0.0000317
AC:
1
AN:
31592
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39124
South Asian (SAS)
AF:
0.00
AC:
0
AN:
71358
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48284
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5348
European-Non Finnish (NFE)
AF:
0.00000279
AC:
3
AN:
1074412
Other (OTH)
AF:
0.00
AC:
0
AN:
56738
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152324
Hom.:
0
Cov.:
34
AF XY:
0.000161
AC XY:
12
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41568
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000313
Hom.:
0
Bravo
AF:
0.000174
ExAC
AF:
0.0000507
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Nov 17, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.P127L variant (also known as c.380C>T), located in coding exon 5 of the RECQL4 gene, results from a C to T substitution at nucleotide position 380. The proline at codon 127 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.

not provided Uncertain:1
Jun 25, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Has not been previously published as pathogenic or benign to our knowledge; In silico analysis does not support a benign or deleterious effect of this variant on protein structure/function

RECQL4-related disorder Uncertain:1
Sep 26, 2022
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The RECQL4 c.380C>T variant is predicted to result in the amino acid substitution p.Pro127Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.047% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-145742123-G-A) and is interpreted as uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/239772/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

Baller-Gerold syndrome Uncertain:1
Jan 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 127 of the RECQL4 protein (p.Pro127Leu). This variant is present in population databases (rs550470182, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 239772). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RECQL4 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
9.1
DANN
Benign
0.40
DEOGEN2
Benign
0.058
T
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.50
T
M_CAP
Benign
0.0010
T
MetaRNN
Benign
0.023
T
PhyloP100
-0.032
PrimateAI
Benign
0.31
T
Sift4G
Benign
0.26
T
Polyphen
0.032
B
Vest4
0.076
MVP
0.62
GERP RS
0.24
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.0
Varity_R
0.033
gMVP
0.26
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs550470182; hg19: chr8-145742123; API